Affinicon

Antibody-drug conjugate technology platform for targeted delivery of known drugs to macrophages.

placeAarhus, Capital Region Of Denmark, Denmark calendar_todayFounded 2013 groups3 employees language affinicon.com

Innovation

2 patent families (2 granted) — focus: Human necessities, Physics & computing; filing pace dormant. Cited 108 times.

YearFilings
20161
20171

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon